Longeveron Inc. Stock News

Live conference call on Friday, March 10 at 8:30 a.m. ET Live conference call on Friday, March 10 at 8:30 a.m. ET

In November 2021, I made an outlandish effort to pick 5 cheap stocks that could double within a month. Few companies rise 100%, and even fewer can do it in the time it takes to properly pickle a cucum

MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, t

Longeveron Inc. (NASDAQ:LGVN ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Representatives Dr. Chris Min - Interim Chief Executive Officer, Chief Medical Officer Dr. Joshua H

Live conference call on Monday, November 14 at 8:30 a.m. EST Live conference call on Monday, November 14 at 8:30 a.m. EST

MIAMI, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, a

Source: shutterstock.com/Anastasia Zagoruyko Longeveron (NASDAQ: LGVN ) stock is on the move Wednesday after the FDA granted its fast-track designation for Lomecel-B. Lomecel-B is a allogeneic, bone m

      Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker   Issued claims will protect use of a biomarker to assess response to Lomecel-B in patients with blood vessel dysfunction.   Miami, Florida – August 25, 2022 -- InvestorsHub NewsWire -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology compa...

Longeveron Inc. (NASDAQ:LGVN ) Q2 2022 Earnings Conference Call August 12, 2022 8:30 AM ET Company Participants Elsie Yau - Stern Investor Relations Chris Min - Interim Chief Executive Officer & Chief

Live conference call on Friday, August 12 at 8:30 a.m. EST Live conference call on Friday, August 12 at 8:30 a.m. EST

Longeveron Inc. (NASDAQ:LGVN ) Q1 2022 Earnings Conference Call May 13, 2022 8:30 AM ET Company Participants Elsie Yau - Stern Investor Relations, IR Geoff Green - CEO Chris Min - Chief Medical Office

Live conference call at 8:30 a.m. EST Live conference call at 8:30 a.m. EST

These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments.

A phase 2a study using Lomecel-B for Alzheimer's Disease is currently enrolling patients; a prior phase 1 study established excellent safety profile with some efficacy. The global Alzheimer's Disease

April events to highlight Longeveron's commitment to developing cell therapeutics for chronic aging related diseases. April events to highlight Longeveron's commitment to developing cell therapeutics